Prostate cancer metastatic castration-resistant
Clinical trials for Prostate cancer metastatic castration-resistant explained in plain language.
Never miss a new study
Get alerted when new Prostate cancer metastatic castration-resistant trials appear
Sign up with your email to follow new studies for Prostate cancer metastatic castration-resistant, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Double radiation attack aims to stop prostate cancer bone breaks
Disease control Recruiting nowThis phase 2 trial tests whether adding precise external beam radiation to standard radioligand therapy can better control metastatic prostate cancer that no longer responds to hormone therapy. About 120 participants will receive either standard treatment alone or combined with t…
Matched conditions: PROSTATE CANCER METASTATIC CASTRATION-RESISTANT
Phase 2 • Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New drug duo takes on tough prostate cancers
Disease control Recruiting nowThis phase 2 trial is testing a combination of two drugs—sacituzumab tirumotecan and tagitanlimab—in people with aggressive variant or neuroendocrine prostate cancer that has progressed after prior treatments. The study aims to see if the combo can shrink tumors and delay disease…
Matched conditions: PROSTATE CANCER METASTATIC CASTRATION-RESISTANT
Phase 2 • Sponsor: Tianjin Medical University Second Hospital • Aim: Disease control
Last updated Jun 26, 2026 18:44 UTC